European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab) European Medicines Agency, 2005 Accessed on 6 Dec 2011 from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000353/WC500025264.pdf. CommentRecommendBookmarkWatch